Jung Foundation honours pioneering research approaches for new cancer therapies, neurodegenerative diseases and infections

Prof. Elena Conti, PhD (Munich) and Prof. Dr Jörn Piel (Zurich) receive long-established Jung Prize for Medicine, Dr med. Benjamin Ruf, MD (Tübingen) honoured with Jung Career Advancement Award, Prof. Wolf-Herman Fridman, MD, PhD, (Paris) awarded Jung Gold Medal for Medicine

Which researchers are making decisive advances in medicine? Today, the Hamburg Jung Foundation for Science and Research honours ground-breaking discoveries that open up new avenues in the treatment of serious diseases. The Hamburg-based, independent foundation has been awarding the prestigious and highly endowed Jung Prize for Medicine since 1976. This year, the foundation is honouring Prof. Elena Conti, PhD, Director at the Max Planck Institute of Biochemistry in Martinsried near Munich, and Prof. Dr Jörn Piel, microbiologist and head of the Bacterial Natural Products research group at the Institute of Microbiology at ETH Zurich. The Jung Career Advancement Award goes to Dr med. Benjamin Ruf, physician and researcher at the Faculty of Medicine and the Department of Internal Medicine I in Tübingen. With the Jung Gold Medal for Medicine, the Jung Foundation honours the scientific life’s work of Prof. Wolf-Herman Fridman, MD, PhD, Professor Emeritus of Immunology at the Cordeliers Research Centre of the Université Paris Cité. The award ceremony will take place in the evening at the Hanse Lounge in Hamburg in the intimate setting of the Jung family. With its annual awards, the Jung Foundation honours outstanding scientific achievements that have the potential to change diagnostics and therapy in the long term or have already done so. With the awards and scholarships totalling up to 650,000 euros per year, it promotes excellent science and advances medical innovations that can be decisive for patients worldwide.

Please download the press release here.

High resolution pictures can be downloaded here.

Zur Pressmitteilung

HIV-1: Antibodies with low viral escape identified

A promising option for the prevention and treatment of HIV-1 infections is the use of broadly neutralizing antibodies targeting the HIV-1 envelope protein. However, their clinical application may be limited if the virus develops resistance. With the participation of Ernst Jung career award 2018 winner Till Schoofs, a highly broad and potent antibody has now been discovered that targets the CD4 binding site of HIV-1[1].

Zur Pressmitteilung

Ernst Jung Award winner receives Leibniz Prize

Where there is one prize, a second is soon to follow: In March, our award winner 2018 Professor Dr. Marco Prinz was awarded the prestigious Gottfried Wilhelm Leibniz Prize. The German Research Foundation (DFG) thus honours his outstanding work in the field of neuroimmunology.

Zur Pressmitteilung

Deutschlandstipendien: Jung Foundation for Science and Research supports medical students of the University of Hamburg

For the third time in a row, the Hamburg Jung Foundation for Science and Research is contributing to the Deutschlandstipendien at the University of Hamburg. Students that are especially gifted, engaged in voluntary work or have special needs receive monthly financial support. The University of Hamburg has been awarding Deutschlandstipendien in all faculties since 2015. In accordance with its objective, the Jung Foundation supports medicine students.

Zur Pressmitteilung

Postponed: Jung-Nacht der Medizinischen Forschung

Due to the spread of the coronavirus SARS-CoV-2 and the resulting restrictions to public life, we have decided to postpone our award ceremony to 20 May 2021.

Zur Pressmitteilung